Genetic ablation of ACAT1 lead to increased response from activated T cells in both infection and cancer, and this was attributed to the increased cholesterol in the plasma membrane leading to increased TCR clustering (Molnár et al., 2012; Yang et al., 2016). Here, ACAT1 is linked to cancer.